Kód: 01430514

Molecular Targeting in Oncology

Name: Molecular Targeting in Oncology
Brand: Humana Press Inc.
SKU: 01430514
Price: 6578.00 CZK
Availability: InStock

Autor Howard L. Kaufman, Scott Wadler, Karen Antman

Jazyk: Angličtina
Vazba: Pevná
Počet stran: 728
Nakladatelství: Humana Press Inc., 2008
Více informací o knize

6578 Kč

Skladem u dodavatele v malém množství
Odesíláme za 12-15 dnů

Potřebujete více kusů?Máte-li zájem o více kusů, prověřte, prosím, nejprve dostupnost titulu na naši zákaznické podpoře.

Přidat mezi přání

Mohlo by se vám také líbit

As Long as the Moon Shall Rise: Reflections on the Full Moon
423 Kč
Koupit

Darujte tuto knihu ještě dnes

Objednejte knihu a zvolte Zaslat jako dárek.
Obratem obdržíte darovací poukaz na knihu, který můžete ihned předat obdarovanému.
Knihu zašleme na adresu obdarovaného, o nic se nestaráte.

Více informací

Více informací o knize Molecular Targeting in Oncology

Parametry knihy
Anotace
Oblíbené z jiného soudku

Nákupem získáte 658 bodů

Anotace knihy

This book presents an overview of the development of targeted therapies for the treatment of cancer with an emphasis on clinical application. The volume covers the complexity of the rapidly developing area of targeted therapies for the treatment of patients with cancer. It is structured in a way so readers may begin with chapters that most interest them and work through the rest of the chapters in the order of their choice.In Molecular Targeting in Oncology, authors present an overview of the development of targeted therapies for the treatment of cancer with an emphasis on clinical application. The volume covers the complexity of the rapidly developing area of targeted therapies for the treatment of patients with cancer and is structured in a way so readers may begin with chapters that most interest them and work through the rest of the chapters in the order of their choice.§The volume is divided into five sections that cover the most important elements of drug development. The first section focuses on approaches using targeted therapies to inhibit cell growth. The second section describes how clinicians are evaluating targeted therapies in specific organ systems. The third section illustrates how various classes of pharmacologic and immunologic agents are developed for individual molecular targets. The fourth section details new drugs that have novel mechanisms of action. The final section looks to the future of targeted therapeutics and includes chapters on appropriate patient selection, use of combination therapy, dealing with tumor cell resistance, and more. Comprehensive and cutting-edge, Molecular Targeting in Oncology is an essential reference for those working in the field.